
CureFit, the Bengaluru-based health and fitness startup, significantly shrank its net loss by 83% in FY25, bringing it down to ₹483 crore compared to the previous year's ₹888 crore loss. This improvement aligns with the firm's strategic focus on revenue growth and operations restructuring.
In FY25, CureFit reported a substantial increase in operating revenue, rising 31% to ₹1,215 crore from ₹926.6 crore in FY24. Including additional income of ₹56.4 crore, the startup's total revenue touched ₹1,272 crore for the year. The core of its revenue came from services, which amounted to ₹841.3 crore. Additionally, the direct-to-consumer fitness apparel business contributed ₹326.4 crore.
Besides its core fitness services, CureFit earned around ₹50 crore from its franchising model. However, the fiscal year also involved key strategic shifts with the discontinuation of brands like Onyx and Trade.fit, resulting in impairment costs. Intangible assets from these brands were impaired to the tune of ₹10.7 crore for Onyx and ₹27 lakh for Trade.fit.
With a strategic focus on cost efficiency, CureFit managed to keep its expenses in check. Employee expenses rose slightly by 7% to ₹347.4 crore, whereas facility management costs increased by 28% to ₹129.3 crore. Conversely, promotional and advertisement expenses were reduced by 3%, settling at ₹203 crore.
Read More: Sri Lotus Developers Share Price in Focus; Incorporates Sri Lotus Elegancia Realty as Wholly Owned Unit!
CureFit saw impairment costs of ₹319.3 crore due to its restructuring efforts, which included sunsetting apps like Fitternity and Fitso. These strategic adjustments were critical in streamlining operations, paving the way for future profitability goals.
The reductions in losses and improvements in revenue highlight CureFit’s focused efforts to optimise its operations while navigating significant restructuring activities. The company's strategic adjustments have laid the groundwork for a stronger financial performance in upcoming years.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investin
Published on: Mar 14, 2026, 10:32 AM IST

Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
